English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 903790      線上人數 : 588
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版

    子類別

    會議論文/會議摘要 [1/3]
    期刊論文 [13/13]

    鄰近社群


    于重元 [19/19]
    劉柯俊 [85/98]
    劉滄梧 [119/125]
    劉界元(2003-2010) [3/3]
    夏和雄(1996-2012) [26/31]
    夏興國 [51/54]
    姜乃榕 [82/94]
    常慧如 [39/44]
    張俊彥 [234/254]
    張光裕 [69/79]
    張憶壽 [103/106]
    張文祥 [52/53]
    張書銘 [89/91]
    彭汪嘉康(1996-2007) [120/126]
    施能耀 [37/43]
    李家惠 [29/29]
    李岳倫 [48/49]
    林素芳 [32/32]
    楊奕馨 [41/42]
    江士昇 [88/90]
    洪文俊 [88/88]
    莊雙恩 [82/91]
    蔡坤志 [32/34]
    蔡慧珍 [66/71]
    蘇勇曄 [40/40]
    蘇振良 [24/25]
    郭靜娟 [71/76]
    陳尚鴻 [45/48]
    陳振陽 [72/72]
    陳立宗 [443/510]
    陳美霞(2002-2009) [1/1]
    陳詩政 [2/2]
    陳雅雯 [38/39]
    黃智興 [55/55]
    黃道揚 [26/26]
    丁兆治(2000-2004) [5/5]
    其他 [464/471]
    劉敏(1996-2007) [60/62]
    劉玫英(2004-2006) [2/2]
    吳成文(1996-2008) [53/55]
    曾思文(1997-2007) [4/4]
    李冠德(1997-2004) [4/6]
    林景太(1999-2007) [5/5]
    楊文光(1996-1999) [21/21]
    王全正(1996-2003) [4/4]
    莊聲宏(1997-2004) [11/11]
    詹宗晃(2000-2008) [2/2]
    賴基銘(2004-2008) [41/47]
    阮麗蓉(2000-2006) [6/7]
    陳俊叡(2003-2007) [6/6]
    馬彥英(1997-1999) [1/1]
    黃奇英(2005-2007) [9/10]

    社群統計


    近3年內發表的文件:9(56.25%)
    含全文筆數:14(87.50%)

    文件下載次數統計
    下載大於0次:14(100.00%)
    下載大於100次:11(78.57%)
    檔案下載總次數:2805(0.05%)

    最後更新時間: 2024-12-01 03:14

    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目1-16 / 16. (共1頁)
    1 
    每頁顯示[10|25|50]項目

    日期題名關聯
    2024-09-27 DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer Oncogenesis. 2024 Sep 27;13:Article number 34.
    2024-06-10 APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance Nucleic Acids Research. 2024 Jun 10;52(10):5676-5697.
    2024-03 RNF43 inactivation enhances the B-RAF/MEK signaling and greates a combinatory therapeutic target in cancer cells Advanced Science. 2024 Mar;11(12):Article number e2304820.
    2023-11-01 Exon junction complex mediates the cap-independent translation of circular RNA Molecular Cancer Research. 2023 Nov 1;21(11):1220-1233.
    2023-01 TRPM1 promotes tumor progression in acral melanoma by activating the Ca2+/CaMKIIdelta/AKT pathway Journal of Advanced Research. 2023 Jan;43:45-57.
    2022-12 PARP1 recruits DNA translocases to restrain DNA replication and facilitate DNA repair PLoS Genetics. 2022 Dec;18(12):Article number e1010545.
    2022-11 CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer British Journal of Cancer. 2022 Nov;127(9):1615-1628.
    2022-05-15 Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients American Journal of Cancer Research. 2022 May 15;12(5):2084-2101.
    2022-04-06 STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming Nature Communications. 2022 Apr 06;13:Article number 1859.
    2021-07-23 AUY922 induces retinal toxicity through attenuating TRPM1 Journal of Biomedical Science. 2021 Jul 23;28:Article number 55.
    2021-01-19 NECTIN4: A novel therapeutic target for melanoma International Journal of Molecular Sciences. 2021 Jan 19;22(2):Article number 976.
    2020-08 Mutation of the STK11 gene predicts recurrence of breast cancer Cancer Research. 2020 Aug;80(16):Abstract number 2487.
    2020-05 Modulating tumor immune microenvironment by the STK11/LKB1 signaling in breast cancer Journal of Clinical Oncology. 2020 May;38(15, Suppl.):Abstract number e15185.
    2020-03-04 Immunohistochemical BRAF V600E expression and intratumor BRAF V600E heterogeneity in acral melanoma: Implication in melanoma-specific survival Journal of Clinical Medicine. 2020 Mar 4;9(3):Article number 690.
    2019-09 Prognostic and clinicopathologic associations of Casein Kinase (CK) 1 alpha in acral lentiginous melanoma Journal of Investigative Dermatology. 2019 Sep;139(9):S299.
    2019-02-18 The potential of targeting P53 and HSP90 overcoming acquired MAPKi-Resistant melanoma Current Treatment Options in Oncology. 2019 Feb 18;20(3):Article number 22.

    顯示項目1-16 / 16. (共1頁)
    1 
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋